Renalytix Plc (LON:RENX – Get Free Report) shares fell 13.5% during trading on Monday . The stock traded as low as GBX 7.55 ($0.10) and last traded at GBX 8 ($0.11). 360,311 shares changed hands during mid-day trading, a decline of 25% from the average session volume of 478,805 shares. The stock had previously closed at GBX 9.25 ($0.12).
Renalytix Trading Down 13.5 %
The firm has a 50-day moving average of GBX 12.01 and a 200 day moving average of GBX 18.90. The company has a current ratio of 0.42, a quick ratio of 2.42 and a debt-to-equity ratio of 173.95. The stock has a market capitalization of £13.27 million, a price-to-earnings ratio of -28.45 and a beta of 2.10.
About Renalytix
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Further Reading
- Five stocks we like better than Renalytix
- How to Buy Cheap Stocks Step by Step
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- What are earnings reports?
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- There Are Different Types of Stock To Invest In
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
